SSR

SSR Health is a specialized investment research firm that provides deep-dive analysis and data-driven insights into the global healthcare and biopharmaceutical sectors. The company is widely recognized for its proprietary models on drug pricing, net-to-gross dynamics, and therapeutic area market trends, serving institutional investors and corporate strategists. By integrating clinical data with financial and regulatory analysis, SSR Health offers a unique perspective on the commercial viability of emerging therapies and established franchises. Their research often focuses on the impact of policy changes, such as the Inflation Reduction Act, on the long-term valuation of biotech and pharma companies.